Stock Market Reviews

IMCC (IM Cannabis Corp.) News

Get the latest news, insights, and market updates on IMCC (IM Cannabis Corp.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• IM Cannabis Explores U.S. Market Entry Following President Trump's Executive Order on Increasing Medical Marijuana and Cannabidiol Research
  IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), medical cannabis company with operations in Israel and Germany, today announced that it is actively evaluating certain strategic opportunities to expand its operations into the United States cannabis market. This initiative follows President Donald Trump's executive order signed on December 18, 2025, which directs the Attorney General to expedite the rescheduling of marijuana from Schedule I to Schedule III under the Controlled Substance
  Dec 30, 2025 - $IMCC
• IM Cannabis Appoints Asi Levi as Chief Financial Officer
  IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, today announced, further to its press release dated October 29, 2025, the appointment of Asi Levi, CPA, as the Company's Chief Financial Officer ("CFO"), effective immediately, to replace Uri Birenberg.
  Dec 12, 2025 - $IMCC
• IM Cannabis Reports Third Quarter 2025 Financial Results
  IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today for the third quarter and nine months ended September 30, 2025. All amounts are reported in Canadian dollars and compared to the quarter and nine months ended September 30, 2024, unless otherwise stated.
  Nov 13, 2025 - $IMCC
• IM Cannabis to Report third Quarter 2025 Financial Results on Thursday, November 13th at 9:00am ET
  IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the third quarter 2025 ended September 30, 2025, on Thursday, November 13, 2025, before the market opens.
  Nov 6, 2025 - $IMCC
• IM Cannabis' Market Cap Drops To US$7.4m Leaving Insiders With Losses
  Insiders who acquired CA$1.13m worth of IM Cannabis Corp.'s ( NASDAQ:IMCC ) stock at an average price of CA$2.07 in the...
  Oct 30, 2025 - $IMCC
• IM Cannabis Announces CFO Departure
  IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading international medical cannabis company with operations in Israel and Germany, today announced that Uri Birenberg, the Company's Chief Financial Officer, will be stepping down from his role for personal reasons. Mr. Birenberg is expected to continue serving as Chief Financial Officer until January 5, 2026, or such earlier date as may be determined by the Company, and will assist in a structured transition process
  Oct 29, 2025 - $IMCC
• IM Cannabis Signs Non-Binding Term Sheet to Acquire 60% Stake in Innovative Quantum Computing Bio Data Company for Up to $54 Million
  IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC), a leading medical cannabis company with operations in Israel and Germany, today announced the signing of a non-binding indicative term sheet for a proposed securities exchange agreement to acquire a 60% equity interest in a pioneering quantum computing bio data company ("The Target Company") for aggregate consideration of up to $54 million.
  Oct 23, 2025 - $IMCC
• IM Cannabis Announces Board Changes and Strategic Decision to Identify Additional Business Opportunities
  IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, today announced the following changes to its Board of Directors (the "Board").
  Sep 16, 2025 - $IMCC
• IM Cannabis Regains Compliance with Nasdaq Stockholders' Equity Listing Requirement
  IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced that it received notice from Nasdaq on September 4, 2025 that the Company has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders' equity of at least $2,500,000. The Company's common stock will continue to be listed and traded on the Nasdaq Capital Market.
  Sep 5, 2025 - $IMCC
• IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing
  IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC), a leading medical cannabis company with operations in Israel and Germany, announces that it has agreed with holders (each, a "Holder") of common share purchase warrants ("November 2024 Warrants") issued by the Company as part of its non-brokered private placement offering which closed on November 12, 2024 to: (x) reduce the exercise price of each November 2024 Warrant from C$4.32 to C$3.43; and (y) extend the expiration date of e
  Aug 13, 2025 - $IMCC